{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T15:41:37Z","timestamp":1791733297919,"version":"4.3.4"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n The current quality performance measure for colorectal cancer (CRC) screening is limited to initial screening. Despite low rates, there is no measure for appropriate follow-up with colonoscopy after receipt of an abnormal result of a stool-based screening test (SBT) for CRC. A quality performance measure is needed.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To develop and test a quality performance measure for follow-up colonoscopy within 6 months of an abnormal result of an SBT for CRC.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This retrospective quality improvement study examined data from January 1, 2016, to December 31, 2020, with 2018 plus 6 months of follow-up as the primary measurement period to verify performance rates, specify a potential measure, and test for validity, reliability, and feasibility. The Optum Labs Data Warehouse (OLDW), a deidentified database of health care claims and clinical data, was accessed. The OLDW contains longitudinal health information on enrollees and patients, representing a diverse mixture of ages and geographic regions across the US. For the database study, adults from 38 health care organizations (HCOs) aged 50 to 75 years who completed an initial CRC SBT with an abnormal result were observed to determine follow-up colonoscopy rates within 6 months. Rates were stratified by race, ethnicity, sex, insurance, and test modality. Three HCOs participated in the feasibility field testing. Data were analyzed from June 1, 2022, to May 31, 2023.<\/jats:p>\n <\/jats:sec>\n \n Main Outcome and Measures<\/jats:title>\n The primary outcome consisted of follow-up colonoscopy rates following an abnormal SBT result for CRC. Reliability statistics were also calculated across HCOs, race, ethnicity, and measurement year.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among 20\u202f581 adults (48.6% men and 51.4% women; 307 [1.5%] Asian, 492 [7.2%] Black, 644 [3.1%] Hispanic, and 17 705 [86.0%] White; mean [SD] age, 63.6 [7.1] years) in 38 health systems, 47.9% had a follow-up colonoscopy following an abnormal SBT result for CRC within 6 months. There was significant variation between HCOs. Notably, significantly fewer Black patients (37.1% [95% CI, 34.6%-39.5%]) and patients with Medicare (49.2% [95% CI, 47.7%-50.6%]) or Medicaid (39.2% [95% CI, 36.3%-42.1%]) insurance received a follow-up colonoscopy. A quality performance measure that tracks rates of follow-up within 6 months of an abnormal SBT result was observed to be feasible, valid, and reliable, with a median reliability statistic between HCOs of 94.5% (range, 74.3%-99.7%).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n The findings of this observational study of 20\u202f581 adults suggest that a measure of follow-up colonoscopy within defined periods after an abnormal result of an SBT test for CRC is warranted based on low current performance rates and would be feasible to collect by health systems and produce valid, reliable results.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.2693","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T11:01:33Z","timestamp":1711364493000},"page":"e242693","source":"Crossref","is-referenced-by-count":38,"title":["Development of a Follow-Up Measure to Ensure Complete Screening for Colorectal Cancer"],"prefix":"10.1001","volume":"7","author":[{"given":"Elizabeth L.","family":"Ciemins","sequence":"first","affiliation":[{"name":"Research and Analytics, American Medical Group Association, Alexandria, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff T.","family":"Mohl","sequence":"additional","affiliation":[{"name":"Research and Analytics, American Medical Group Association, Alexandria, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Moreno","sequence":"additional","affiliation":[{"name":"Research and Analytics, American Medical Group Association, Alexandria, Virginia"},{"name":"Now with Albany Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Colangelo","sequence":"additional","affiliation":[{"name":"Allegheny Health Network, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Smith","sequence":"additional","affiliation":[{"name":"Center for Cancer Screening, American Cancer Society, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Barton","sequence":"additional","affiliation":[{"name":"National Committee for Quality Assurance, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,3,25]]},"reference":[{"issue":"3","key":"zoi240122r1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.v73.3","article-title":"Colorectal cancer statistics, 2023.","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"zoi240122r2","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/jama.2021.6238","article-title":"Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement.","volume":"325","author":"Davidson","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"zoi240122r3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.14309\/ajg.0000000000001548","article-title":"Updates on age to start and stop colorectal cancer screening: recommendations from the US Multi-Society Task Force on Colorectal Cancer.","volume":"117","author":"Patel","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"zoi240122r4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1053\/j.gastro.2021.10.007","article-title":"Updates on age to start and stop colorectal cancer screening: recommendations from the US Multi-Society Task Force on Colorectal Cancer.","volume":"162","author":"Patel","year":"2022","journal-title":"Gastroenterology"},{"issue":"1","key":"zoi240122r5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gie.2021.06.012","article-title":"Updates on age to start and stop colorectal cancer screening: recommendations from the US Multi-Society Task Force on Colorectal Cancer.","volume":"95","author":"Patel","year":"2022","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"zoi240122r7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1001\/jamaoncol.2016.4227","article-title":"Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis.","volume":"3","author":"Petrelli","year":"2017","journal-title":"JAMA Oncol"},{"issue":"16","key":"zoi240122r8","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1001\/jama.2017.3634","article-title":"Association between time to colonoscopy after a positive fecal test result and risk of colorectal cancer and cancer stage at diagnosis.","volume":"317","author":"Corley","year":"2017","journal-title":"JAMA"},{"key":"zoi240122r9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2147\/CLEP","article-title":"Time to colonoscopy, cancer probability, and precursor lesions in the Danish colorectal cancer screening program.","volume":"11","author":"Kaalby","year":"2019","journal-title":"Clin Epidemiol"},{"issue":"7","key":"zoi240122r10","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cgh.2018.10.041","article-title":"Time to colonoscopy and risk of colorectal cancer in patients with positive results from fecal immunochemical tests.","volume":"17","author":"Lee","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"zoi240122r11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.puhe.2022.06.022","article-title":"Cost of treating metastatic colorectal cancer: a systematic review.","volume":"211","author":"Bhimani","year":"2022","journal-title":"Public Health"},{"issue":"4","key":"zoi240122r12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1200\/JCO.2011.37.5527","article-title":"Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008.","volume":"30","author":"Robbins","year":"2012","journal-title":"J Clin Oncol"},{"issue":"7","key":"zoi240122r13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1001\/archinternmed.2012.332","article-title":"Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.","volume":"172","author":"Inadomi","year":"2012","journal-title":"Arch Intern Med"},{"issue":"4","key":"zoi240122r14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3322\/caac.v68.4","article-title":"Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.","volume":"68","author":"Wolf","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"zoi240122r16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1158\/1055-9965.EPI-15-0470","article-title":"Time to colonoscopy after positive fecal blood test in four US health care systems.","volume":"25","author":"Chubak","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"zoi240122r17","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1007\/s10350-006-0533-2","article-title":"Measuring the quality of colorectal cancer screening: the importance of follow-up.","volume":"49","author":"Etzioni","year":"2006","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"zoi240122r18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/ajg.2016.555","article-title":"Inadequate utilization of diagnostic colonoscopy following abnormal FIT results in an integrated safety-net system.","volume":"112","author":"Issaka","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"zoi240122r19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1001\/jama.2017.11389","article-title":"Effect of colonoscopy outreach vs fecal immunochemical test outreach on colorectal cancer screening completion: a randomized clinical trial.","volume":"318","author":"Singal","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"zoi240122r20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.51384","article-title":"Rates of follow-up colonoscopy after a positive stool-based screening test result for colorectal cancer among health care organizations in the US, 2017-2020.","volume":"6","author":"Mohl","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"8","key":"zoi240122r21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.7326\/M17-1361","article-title":"Interventions to improve follow-up of positive results on fecal blood tests: a systematic review.","volume":"167","author":"Selby","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi240122r22","doi-asserted-by":"publisher","first-page":"I48","DOI":"10.1097\/00005650-200301001-00006","article-title":"Using performance measurement to drive improvement: a road map for change.","volume":"41","author":"Galvin","year":"2003","journal-title":"Med Care"},{"issue":"9","key":"zoi240122r23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.25173","article-title":"Association of hospital public quality reporting with electronic health record medication safety performance.","volume":"4","author":"Holmgren","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"5","key":"zoi240122r24","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1056\/NEJMsa064964","article-title":"Public reporting and pay for performance in hospital quality improvement.","volume":"356","author":"Lindenauer","year":"2007","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi240122r25","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1377\/hlthaff.2017.1678","article-title":"The comprehensive primary care initiative: effects on spending, quality, patients, and physicians.","volume":"37","author":"Peikes","year":"2018","journal-title":"Health Aff (Millwood)"},{"issue":"16","key":"zoi240122r26","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1001\/jama.2014.13109","article-title":"The Pioneer accountable care organization model: improving quality and lowering costs.","volume":"312","author":"Pham","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"zoi240122r27","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1377\/hlthaff.2010.1277","article-title":"The effect of pay-for-performance in hospitals: lessons for quality improvement.","volume":"30","author":"Werner","year":"2011","journal-title":"Health Aff (Millwood)"},{"issue":"6","key":"zoi240122r30","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"36","key":"zoi240122r32","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.15585\/mmwr.mm6936a4","article-title":"Delay or avoidance of medical care because of COVID-19\u2013related concerns\u2014United States, June 2020.","volume":"69","author":"Czeisler","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"zoi240122r33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.36405","article-title":"Assessment of patient preferences for telehealth in post\u2013COVID-19 pandemic health care.","volume":"4","author":"Predmore","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"23","key":"zoi240122r34","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1002\/cncr.v125.23","article-title":"Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 Federally Qualified Health Centers in Southern California: opportunities for improving screening outcomes.","volume":"125","author":"Bharti","year":"2019","journal-title":"Cancer"},{"issue":"3","key":"zoi240122r35","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1177\/2050640619828185","article-title":"The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: a systematic review and meta-analysis.","volume":"7","author":"Gingold-Belfer","year":"2019","journal-title":"United European Gastroenterol J"},{"issue":"5","key":"zoi240122r36","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s11606-021-06922-2","article-title":"A centralized program with stepped support increases adherence to colorectal cancer screening over 9 years: a randomized trial.","volume":"37","author":"Green","year":"2022","journal-title":"J Gen Intern Med"},{"issue":"1","key":"zoi240122r37","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1038\/s41598-020-59032-0","article-title":"Prospective cohort study of predictors of follow-up diagnostic colonoscopy from a pragmatic trial of FIT screening.","volume":"10","author":"O\u2019Connor","year":"2020","journal-title":"Sci Rep"},{"key":"zoi240122r6","author":"Howlader","year":"2020"},{"key":"zoi240122r31","first-page":"112","volume-title":"CMS Measures Management System Blueprint. Version 170. Woodlawn","author":"Centers for Medicare & Medicaid Services","year":"2021"},{"key":"zoi240122r15","unstructured":"European Commission, Directorate-General for Health and Consumers, Executive Agency for Health and Consumers, World Health Organization. Karsa L, Patnick J, Segnan N, eds. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Publications Office of the European Union. December 3, 2010. Accessed January 22, 2023. https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/e1ef52d8-8786-4ac4-9f91-4da2261ee535"},{"key":"zoi240122r28","unstructured":"National Center for Quality Assurance. Colorectal cancer screening (COL, COL-E). 2022. Accessed January 22, 2023. https:\/\/www.ncqa.org\/hedis\/measures\/colorectal-cancer-screening\/"},{"key":"zoi240122r29","doi-asserted-by":"crossref","unstructured":"Adams? J. The reliability of provider profiling: a tutorial. RAND Corporation. June 25, 2009. Accessed September 12, 2023. https:\/\/www.rand.org\/pubs\/technical_reports\/TR653.html","DOI":"10.7249\/TR653"},{"key":"zoi240122r38","unstructured":"American Medical Group Association; AMGA CRC Screening Best Practices Learning Collaborative. 2023-2024. Accessed June 7, 2023. https:\/\/www.amga.org\/performance-improvement\/best-practices\/collaboratives\/crccollab\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2816737\/ciemins_2024_oi_240122_1710778610.51688.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T11:01:38Z","timestamp":1711364498000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2816737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,25]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.2693","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,25]]}}}